Q: In my previous question I asked for your STN latest Q report evaluation. You stated it is coming but i haven't seen it yet.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi Peter and 5i,
Who's your pick for the more growth over the next 5 years between TCS & LMN?
Thanks so much.
Who's your pick for the more growth over the next 5 years between TCS & LMN?
Thanks so much.
Q: Please comment on BTB.un and their recent financials including any going forward comments you may have. Thank you.
Q: May I have your thoughts on BWXT’s latest quarter released yesterday? They are up about 11.5% today so I’m assuming a solid beat. How’s their debt level, are they paying it down? Any thoughts you have would be appreciated.
Regards,
Jim
Regards,
Jim
Q: I have a very small amount invested in ETHX.B and my 22 year-old son is convinced I should have more invested in ethereum. I am a value investor in my 60s and just don't get cryptocurrency. Your comments appreciated regarding the future of ethereum.
Thanks!
Thanks!
Q: Would you please give me your evaluation of FLGT's recent quarter. On the surface it appears quite positive, however the stock is down 10%. Was it their guidance that turned the market sour? I am also perplexed - they state they carry $28/share in cash and marketable securities yet the stock is trading at $23 implying that when you strip out cash the business is worth NEGATIVE $148,000,000. Does this mean the market believes something is fundamentally wrong with the business and/or management? Finally, as a shareholder should I be running for the hills or is this a case of the market mispricing an asset?
Many thanks
Scott
Many thanks
Scott
Q: hi all: LMAT
lamaitre vascular
can you give me your input and outlook for this one?
thanks in advance
lamaitre vascular
can you give me your input and outlook for this one?
thanks in advance
Q: Please comment on the financial results of ACM Research (ACMR); your outlook for the company; and whether you'd consider it buyable. Thanks.
Q: seems to be on a downturn-reports seemed ok prior- could you comment ?
Q: From your point of view, what are the pros and cons of Buffett's preferred ''operating earnings'' metric versus industry-conventionn ''net earnings''?
Thanks
Thanks
Q: What’s your thoughts on today’s earnings and future outlook….
-
BMO MSCI India Selection Equity Index ETF (ZID)
-
iShares India Index ETF (XID)
-
iShares MSCI India ETF (INDA)
Q: What is the best etf or mutual fund to invest in India? As well do you think it is a good area to invest in right now?
Q: Please comment on its QR . Why such a big drop of price?
Q: Hello, you recommended UnitedHealth Group Inc. (UNH) in the past. The recent launch of an antitrust investigation against UNH has led to a sudden drop in the stock price. I’m curious about your thoughts on this investigation. Do you believe it will cause any damage to the company? And considering the circumstances, do you still consider UNH a good buy? Thank you!
Q: Hi folks, opinion on FY23 & Q4 results for Tamarak tve/t....Q4 seems greatly improved operational results, and nice paydown in debt....Buy/Hold/Sell....thanks as always, jb Piedmont QC
Q: Do you consider the dividend streams from the above companies to be safe? Do you forsee issues with even moderate growth for the companies as they say they are diversifying ( cough ). thanks al
Q: How would you rate ILMN overall since 2024? Is it still a takeover target in your estimation and who would be the top ones that would make most sense to acquire ILMN?
Q: Can i get you opinion on TMDX after their latest results? As well, could you please give me your favorite healthcare stocks? And rank them for order of purchase today. Thanks
Q: Hi 5i, this company recently tried to sell itself and there were no takers. They now have decided to let go of 25% of the workforce and buy up to 150 million dollars of shares back.
Looks like they will be cash flow positive by next quarter and are starting to get better traction on selling the drug.
The drug patent is for dosing as the chemical composition expires in a couple years. How would you value this company and would you rate it a buy hold or sell.
Looks like they will be cash flow positive by next quarter and are starting to get better traction on selling the drug.
The drug patent is for dosing as the chemical composition expires in a couple years. How would you value this company and would you rate it a buy hold or sell.
Q: Its my understanding that Coinbase is serving as the custodian for a number of Bitcoin ETFs including iShares Bitcoin ETF IBIT. Does the Canadian ETF BTCC hold its own coins?